Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Alerts
  • Advertising/recruitment
  • Subscribe
  • Contact
  • Current Issue
  • Past Issues
  • By specialty
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews...
    • Mechanisms Underlying the Metabolic Syndrome (Oct 2019)
    • Reparative Immunology (Jul 2019)
    • Allergy (Apr 2019)
    • Biology of familial cancer predisposition syndromes (Feb 2019)
    • Mitochondrial dysfunction in disease (Aug 2018)
    • Lipid mediators of disease (Jul 2018)
    • Cellular senescence in human disease (Apr 2018)
    • View all review series...
  • Collections
    • Recently published
    • In-Press Preview
    • Commentaries
    • Concise Communication
    • Editorials
    • Viewpoint
    • Scientific Show Stoppers
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • About
  • Editors
  • Consulting Editors
  • For authors
  • Current issue
  • Past issues
  • By specialty
  • Subscribe
  • Alerts
  • Advertise
  • Contact
  • Conversations with Giants in Medicine
  • Author's Takes
  • Recently published
  • Brief Reports
  • Technical Advances
  • Commentaries
  • Editorials
  • Hindsight
  • Review series
  • Reviews
  • The Attending Physician
  • First Author Perspectives
  • Scientific Show Stoppers
  • Top read articles
  • Concise Communication
Epac1-dependent phospholamban phosphorylation mediates the cardiac response to stresses
Satoshi Okumura, … , Hikaru Tanaka, Yoshihiro Ishikawa
Satoshi Okumura, … , Hikaru Tanaka, Yoshihiro Ishikawa
Published June 2, 2014; First published April 24, 2014
Citation Information: J Clin Invest. 2014;124(6):2785-2801. https://doi.org/10.1172/JCI64784.
View: Text | PDF
Categories: Research Article Cardiology

Epac1-dependent phospholamban phosphorylation mediates the cardiac response to stresses

  • Text
  • PDF
Abstract

PKA phosphorylates multiple molecules involved in calcium (Ca2+) handling in cardiac myocytes and is considered to be the predominant regulator of β-adrenergic receptor–mediated enhancement of cardiac contractility; however, recent identification of exchange protein activated by cAMP (EPAC), which is independently activated by cAMP, has challenged this paradigm. Mice lacking Epac1 (Epac1 KO) exhibited decreased cardiac contractility with reduced phospholamban (PLN) phosphorylation at serine-16, the major PKA-mediated phosphorylation site. In Epac1 KO mice, intracellular Ca2+ storage and the magnitude of Ca2+ movement were decreased; however, PKA expression remained unchanged, and activation of PKA with isoproterenol improved cardiac contractility. In contrast, direct activation of EPAC in cardiomyocytes led to increased PLN phosphorylation at serine-16, which was dependent on PLC and PKCε. Importantly, Epac1 deletion protected the heart from various stresses, while Epac2 deletion was not protective. Compared with WT mice, aortic banding induced a similar degree of cardiac hypertrophy in Epac1 KO; however, lack of Epac1 prevented subsequent cardiac dysfunction as a result of decreased cardiac myocyte apoptosis and fibrosis. Similarly, Epac1 KO animals showed resistance to isoproterenol- and aging-induced cardiomyopathy and attenuation of arrhythmogenic activity. These data support Epac1 as an important regulator of PKA-independent PLN phosphorylation and indicate that Epac1 regulates cardiac responsiveness to various stresses.

Authors

Satoshi Okumura, Takayuki Fujita, Wenqian Cai, Meihua Jin, Iyuki Namekata, Yasumasa Mototani, Huiling Jin, Yoshiki Ohnuki, Yayoi Tsuneoka, Reiko Kurotani, Kenji Suita, Yuko Kawakami, Shogo Hamaguchi, Takaya Abe, Hiroshi Kiyonari, Takashi Tsunematsu, Yunzhe Bai, Sayaka Suzuki, Yuko Hidaka, Masanari Umemura, Yasuhiro Ichikawa, Utako Yokoyama, Motohiko Sato, Fumio Ishikawa, Hiroko Izumi-Nakaseko, Satomi Adachi-Akahane, Hikaru Tanaka, Yoshihiro Ishikawa

×

Figure 9

A schematic model of cAMP/EPAC signaling as opposed to cAMP/PKA signaling in the heart.

Options: View larger image (or click on image) Download as PowerPoint
A schematic model of cAMP/EPAC signaling as opposed to cAMP/PKA signalin...
Ca2+ stored in the SR is released into the cytosol to activate cardiac muscle contraction and subsequently reaccumulated to promote relaxation. PLN phosphorylation on serine-16 as well as threonine-17 occurs via the EPAC/PLC/PKCε/CaMKII pathway (27, 28). However, under physiological conditions, PLN phosphorylation on serine-16 by PKA rather than on threonine-17 by CaMKII is the major regulator of Ca2+ cycling in the heart (56, 57). Our current study indicates that PLN on serine-16 and RyR2 on serine-2808 and serine-2814 are phosphorylated by EPAC1 in addition to and independently of PKA or CaMKII. More importantly, hyperphosphorylation of PLN on serine-16 was recently reported to be associated not only with an increase in cardiac function in young animals (16, 17), but also with arrhythmia and cardiomyopathy after adrenergic stress, aortic banding, or ischemia (18, 20, 21). Our results suggest that Epac1-mediated hyperphosphorylation of PLN and RyR2 might be required for the development of heart failure as well as arrhythmia, in addition to PKA- or CaMKII mediated activation.
Follow JCI:
Copyright © 2019 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts